Nasdaq trade halt: news pending at 4:00 p.m.
AYTU•Nasdaq halted trading in Aytu BioPharma pending news at 4:00 p.m.
Related News

AI reshapes expert discovery in life sciences, Definitive Healthcare says
DH•

Traws Pharma Q3 2026 net loss narrows 10% to $3.55 million
TRAW•

Everus authorizes new $100 million share buyback program
ECG•

TPG GP A reports disposal of $484.78 million in LifeStance Health common shares
LFST•

MediciNova names CEO Yuichi Iwaki interim CFO
MNOV•